DrugDashboards

Doxazosin Mesylate

Doxazosin Mesylate · DOXAZOSIN MESYLATE 4 mg/1 · Tablet · Oral · Unichem Pharmaceuticals (USA), Inc.

NDC 29300-0353-01 · 100 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

12 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.0857 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0857per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.2035per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.0857per TABweighted avg manufacturer price $0.0381 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1Dec 2024Sep 2026$0.0857
22 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$2.57
#90 count
$7.71

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$17,188
1,452 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for doxazosin mesylate (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA212329
TE code
AB
Approval date
Jan 10, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · OngoingJan 21, 2026
    Unichem Pharmaceuticals USA Inc. — Tablets/Capsules Imprinted with Wrong ID

Manufacturers of Doxazosin Mesylate (Tablet)

LabelerStrengthFirst seenLast seen
Aphena Pharma Solutions - Tennessee, LLCDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
A-S Medication SolutionsDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.DOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.DOXAZOSIN MESYLATE 8 mg/1Aug 5, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.DOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Northwind Health Company, LLCDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Manufacturing Deutschland GmbHDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Manufacturing Deutschland GmbHDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Manufacturing Deutschland GmbHDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Pfizer Manufacturing Deutschland GmbHDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.DOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Unichem Laboratories Limited, IndiaDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.DOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.DOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.DOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Unichem Pharmaceuticals (USA), Inc.DOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith laboratories, LLCDOXAZOSIN MESYLATE 8 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith laboratories, LLCDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith laboratories, LLCDOXAZOSIN MESYLATE 1 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith laboratories, LLCDOXAZOSIN MESYLATE 2 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Aug 31, 2026
A-S Medication SolutionsDOXAZOSIN MESYLATE 4 mg/1Jul 15, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Doxazosin Mesylate — NDC 29300-0353-01," retrieved September 3, 2026, https://drugdashboards.com/drug/29300035301.

Free to cite with attribution — see how the data is put together.